Rainbow Childrens Medicare Ltd (RAINBOW) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 543524 | NSE: RAINBOW | Hospital & Healthcare Services | Small Cap

RainbowChildrenS Med Share Price

1,163.30 -0.15 -0.01%
as on 30-Mar'26 16:59

DeciZen - make an informed investing decision on RainbowChildrenS Med

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Rainbow Childrens Medicare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
48.17
Market Cap:
11,814.4 Cr.
52-wk low:
1,008.8
52-wk high:
1,644.1

Is Rainbow Childrens Medicare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of RainbowChildrenS Med: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rainbow Childrens Medicare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%12.9%14.4%20.3%32.9%21.9%40.5%37.2%29.4%28.5%-
Value Creation
Index
NA0.00.10.51.40.61.91.81.21.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 03214025436956149251,1141,2371,4551,492
Sales YoY Gr.-NA25.1%35.1%28.1%-11.6%50.5%20.5%11%17.6%-
Adj EPS 03.546.67.95.515.120.621.223.424.2
YoY Gr.-NA15.2%64.8%18.9%-30.3%175%36.8%2.7%10.5%-
BVPS (₹) 034.938.744.74651.666.5107.2125.7146.4162.4
Adj Net
Profit
031.436.159.670.949.4142209215238245
Cash Flow from Ops. 035.647.995.9178142214316306385-
Debt/CF from Ops. 00.40.30.50.30.30.2000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA15.9%16.3%17.6%
Adj EPS NA24.4%15.8%10.5%
BVPSNA26.1%30.1%16.5%
Share Price - - 16.8% -16.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
09.610.615.416.91125.524.318.117.115.6
Op. Profit
Mgn %
017.117.320.7302732.334.633.732.932.3
Net Profit
Mgn %
09.891110.2815.318.817.416.316.4
Debt to
Equity
00.100.10.10.10.1000-
Working Cap
Days
00121781041378614917810787
Cash Conv.
Cycle
00-18-7-5-4-9-13-9-568

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Rainbow Childrens Medicare Ltd.

Standalone Consolidated
TTM EPS (₹) 24.2 25.4
TTM Sales (₹ Cr.) 1,492 1,613
BVPS (₹.) 162.4 156.7
Reserves (₹ Cr.) 1,548 1,490
P/BV 7.16 7.42
PE 48.17 45.86
From the Market
52 Week Low / High (₹) 1008.75 / 1644.10
All Time Low / High (₹) 410.00 / 1708.50
Market Cap (₹ Cr.) 11,814
Equity (₹ Cr.) 101.6
Face Value (₹) 10
Industry PE 79.6

Management X-Ray of RainbowChildrenS Med:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of RainbowChildrenS Med - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of RainbowChildrenS Med

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3214025436956149251,1141,2371,455
Operating Expenses 266332430486449626729820976
Manufacturing Costs2936189236217270362412494
Material Costs52608010297188150157190
Employee Cost 69777910296109136169198
Other Costs 11615982463859808295
Operating Profit 5570112209166299385417479
Operating Profit Margin (%) 17.1%17.3%20.7%30.0%27.0%32.3%34.6%33.7%32.9%
Other Income 11109121221313749
Interest 346474453555974
Depreciation 22283665687784105132
Exceptional Items 000000-500
Profit Before Tax 41477910966190273289322
Tax 101120381647677484
Profit After Tax 3136607149142206215238
PAT Margin (%) 9.8%9.1%11.0%10.2%8.0%15.4%18.5%17.4%16.3%
Adjusted EPS (₹)3.44.06.67.95.515.120.321.223.4
Dividend Payout Ratio (%)8%12%7%12%0%13%15%14%13%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3263594144264766361,0881,2761,487
Share Capital 2055555555105102102102
Reserves 3063043593714215319871,1741,385
Minority Interest000000000
Debt151250504127000
Long Term Debt101050464127000
Short Term Debt520400000
Trade Payables202434425159757686
Others Liabilities 724958573501551564773753
Total Liabilities 4334455551,0911,0681,2741,7282,1252,326

Fixed Assets

Gross Block1923404158099351,0951,2591,6931,974
Accumulated Depreciation224883146213283368474606
Net Fixed Assets 1712933336637228138911,2191,368
CWIP 7122143296232028
Investments 605243742105346596
Inventories76715914182323
Trade Receivables141529374541517278
Cash Equivalents 883669948517537717
Others Assets 1408392216141183603439215
Total Assets 4334455551,0911,0681,2741,7282,1252,326

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 364896178142214316306385
PBT 41477910966190273289322
Adjustment 122032102100110116130152
Changes in Working Capital -10-6-0-132-235-27-5
Tax Paid -8-13-15-20-27-62-78-86-84
Cash Flow From Investing Activity -33-42-125-123-87-169-460-214-263
Capex -56-151-80-61-75-58-140-352-143
Net Investments -45-30-25-18-103-345101-141
Others 28103-16-367-8243721
Cash Flow From Financing Activity -1-731-54-56-41148-97-113
Net Proceeds from Shares 000002628000
Net Proceeds from Borrowing 131401-5-6-4000
Interest Paid -1-2-1-5-5-5-300
Dividend Paid -3-3-6-170-9-20-30-30
Others -10-3-2-33-46-48-69-67-83
Net Cash Flow 2-221-243-49

Finance Ratio

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.961115.8817.3411.2326.124.0318.1817.2
ROCE (%)12.9414.3620.3132.9421.8840.4937.1729.3728.54
Asset Turnover Ratio0.740.921.090.840.570.790.740.640.65
PAT to CFO Conversion(x)1.161.331.62.512.91.511.531.421.62
Working Capital Days
Receivable Days161315172417151819
Inventory Days864675566
Payable Days142135132136175107163176156

Rainbow Childrens Medicare Ltd Stock News

Rainbow Childrens Medicare Ltd FAQs

The current trading price of RainbowChildrenS Med on 30-Mar-2026 16:59 is ₹1,163.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Mar-2026 the market cap of RainbowChildrenS Med stood at ₹11,814.4.
The latest P/E ratio of RainbowChildrenS Med as of 29-Mar-2026 is 48.17.
The latest P/B ratio of RainbowChildrenS Med as of 29-Mar-2026 is 7.16.
The 52-week high of RainbowChildrenS Med is ₹1,644.1 and the 52-week low is ₹1,008.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of RainbowChildrenS Med is ₹1,492 ( Cr.) .

About Rainbow Childrens Medicare Ltd

Rainbow Children’s Medicare (Rainbow), founded in 1998, has established itself as a leading healthcare provider specializing in pediatrics, obstetrics and gynecology. The company began its journey in 1999 by opening a 50-bed pediatric multi-specialty hospital in Banjara Hills. In 2009, Rainbow expanded its services to include maternity care (gynecology/ obstetrics). Dr. Ramesh Kancharla, an expert in pediatric hepatology and liver transplantation, leads the company. Rainbow implements a hub-and-spoke operational model to provide its services effectively. The central hospitals focus on delivering comprehensive outpatient and inpatient care, particularly tertiary and quaternary services. Meanwhile, the satellite centers provide emergency care, outpatient consultations and level 3 NICU (Neonatal Intensive Care Unit) services.

Rainbow has successfully implemented this model in Hyderabad and Bengaluru and the company actively works to replicate its approach in Chennai and the National Capital Region. Rainbow actively provides a wide range of pediatric services, including natal, neonatal and pediatric intensive care, multi-specialty treatments and advanced quaternary care such as multi-organ transplants for children.

The company delivers women’s healthcare services under the ‘Birthright by Rainbow’ brand, offering comprehensive perinatal care, which includes routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support and a variety of gynecology treatments. Rainbow has made significant strides in expanding its IVF (In Vitro Fertilization) services across the group. Moreover, Rainbow has launched a pilot project called the Adult Vaccination Outreach Program (AVON) in collaboration with the top five vaccine manufacturing companies. This initiative aims to address the immunization needs of families and will cover vaccines such as Influenza, HPV, Pneumococcal and Shingles.

Business area of the company

Rainbow Children’s Medicare is primarily engaged in the business of rendering medical and healthcare services. The company’s pediatric services under ‘Rainbow Children’s Hospital’ include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including organ transplantation); whereas its women care services under ‘Birthright by Rainbow’ offers perinatal care services which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care along with gynecology services.

Key awards, accreditations or recognitions:

  • 2010: Rainbow Children’s Hospital, Hyderabad received CNBC ICICI Lombard Award for specialty hospital pediatrics.
  • 2014: Rainbow Hospitals, Hyderabad received the CNBC ICICI Lombard Award for the best single specialty hospital pediatrics.
  • 2015: The Company was awarded a certificate of recognition for the project “Rainbow digital” at the 4th Annual Healthcare Leaders’ Awards.
  • 2015: The Company was awarded the Best Hospital in Paediatric & Gynaecology Care at the Asia Healthcare Excellence Awards.
  • 2016: The Company was awarded a certificate of merit for “The best mobile App” at World Marketing Congress.
  • 2017: “Rainbow Children’s Hospital” was awarded the best hospital of the year in pediatrics at Times Health Achievers Telugu States.
  • 2017: The Company was awarded the “Best Single Specialty Hospital” at World Health & Wellness Congress & Awards.
  • 2018: BirthRight by Rainbow Hospitals was awarded India’s No.1 Obstetrics Hospital by the Times of India.
  • 2019: Rainbow Children’s Hospital was awarded best hospital of the year 2019 in Pediatrics at Times Healthcare Achievers Telugu States.
  • 2019: BirthRight by Rainbow Hospitals was awarded the best hospital of the year 2019 in obstetrics and gynecology award at Times Healthcare Achievers Telugu States.
  • 2020: The company was certified as a great workplace by Great Place to Work Institute, India.
  • 2020: The Company was awarded the Healthcare Leadership Award at Karnataka Healthcare Leadership Awards, 2020.
  • 2021 Rainbow Children’s Hospital was awarded as the best standalone pediatrics hospital in India by The Week.
  • 2022: The Company has been certified as a great place to work after an assessment conducted by Great Place to Work Institute, India.
  • 2022: BirthRight Fertility by Rainbow Hospitals was granted the status of ‘accredited’ by Joint Commission International.
  • 2023: Ranked No. 1 in National Single Speciality – Pediatrics Times Critical Care Survey 2022, 2023.
  • 2024: Best Hospital for Mother & Childcare Best Hospital for Obstetrics and Gynecology 2024.
  • 2024: Rainbow Children's Hospital Marathahalli, Bengaluru Accredited by JCI in 2024.
  • 2025: Best Organisation for Women 2025.
  • 2025: Rainbow Children's Hospital & BirthRight, Secunderabad & Marathahalli World's Best Specialized Hospitals 2025.
  • 2025: Rainbow Children's Heart Institute Hyderabad. World's Best Specialized Hospitals 2025.

Major events and milestones

  • 1999: Established company’s first hospital at Banjara Hills.
  • 2005: Expansion of Banjara Hills Facility to tertiary care.
  • 2007: Established Hospital at Vijayawada.
  • 2009: Established Hospital at Vikrampuri.
  • 2010: Opening of outpatient clinic at Madhapur.
  • 2010: Established IVF facility at Madhapur.
  • 2013: Established hospital at Kondapur.
  • 2013: British International Investment plc (formerly known as CDC Group plc) subscribed to 1,146,771 equity shares and 1,146,771 Series A CCPS of the Company.
  • 2013: Rainbow Institute of Medical Sciences Private Limited changed in place of business to 332, 4B, C1, Currency Nagar, Vijayawada-8.
  • 2015: Established hospital at Hydernagar.
  • 2015: Established hospital at Marathalli.
  • 2016: CDC India subscribed to 1,133,309 Series B CCPS of Company.
  • 2016: Established Hospital at Bannerghatta Road, Bangalore.
  • 2016: Established hospital at LB Nagar, Hyderabad, Telangana.
  • 2017: Madhukar Rainbow Hospital at New Delhi commenced operations.
  • 2018: Established Hospital at Guindy, Chennai.
  • 2019: One of the company’s subsidiaries, Rosewalk Healthcare Private Limited received certificate of establishment.
  • 2019: Started outpatient and IVF facility at Kondapur.
  • 2019: Commencement of Rainbow Children’s Heart Institute (a unit of Rainbow Speciality Hospitals Pvt Ltd).
  • 2020: Established hospital at Byatarayanapura village, Yelahanka, Hubli, Bengaluru.
  • 2020: Established hospital at Vizag.
  • 2021: Relocated and expanded its hospital at Vikrampuri.
  • 2021: Started liver transplant services at Banjara Hills, Hyderabad.
  • 2022: Listed on BSE and NSE.
  • 2022: Added a spoke hospital at Sholinganallur, Chennai.
  • 2022: Received JCI accreditation for BirthRight Fertility, Kondapur, Hyderabad.
  • 2023: Established spoke hospital at Financial District, Hyderabad.
  • 2023: Received JCI accreditation for Banjara Hills, Hyderabad.
  • 2024: Received JCI accreditation for Marathahalli, Bengaluru.
  • 2024: Established three spoke hospitals: Himayatnagar, Hyderabad; Sarjapur, Bengaluru; and Annanagar, Chennai.
  • 2024: Expanded capacity by adding a new block at Hydernagar Hospital, Hyderabad.
  • 2024: Established an outpatient clinic at Hennur, Bengaluru.
  • 2024: Added IVF services at 8 hospitals.
  • 2025: Received JCI re-accreditation for BirthRight Fertility, Kondapur, Hyderabad.
  • 2025: Received NABH accreditation for Visakhapatnam.
  • 2025: Performed first liver transplant at Guindy, Chennai.
  • 2025: Received liver transplant license at Marathahalli, Bengaluru.
  • 2025: Commissioned Child development center to provide comprehensive developmental care.
  • 2025: Started ‘Butterfly Essentials’ for Women and Children.
  • 2025: Outpatient clinic opened at Attapur, Hyderabad.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×